Table 2 Clinicopathological characteristics according to visceral adipose tissue content
| Â | Q1 | Q2 | Q3 | Q4 | P |
|---|---|---|---|---|---|
Median age (range) | 57.5 (51.0–62.0) | 60.0 (46.0–68.0) | 46.0 (39.0–57.3) | 51.0 (42.0–54.0) | < 0.001 |
No. gender, n (%) | Â | Â | Â | Â | Â |
Male | 24 (48.0%) | 33 (66.0%) | 46 (92.0%) | 50 (100.0%) | < 0.001 |
Female | 26 (52.0%) | 17 (34.0%) | 4 (8.0%) | 0 (0.0%) | |
Median tumor size (cm) (range) | 1.8 (1.2–2.8) | 2.5 (1.8–3.6) | 1.6 (1.4–1.7) | 2.1 (1.2–2.9) | < 0.001 |
Median BMI (kg/m2) (range) | 22.9 (21.9–24.6) | 24.4 (23.0–26.6) | 27.7 (24.1–29.0) | 27.1 (25.1–29.2) | < 0.001 |
No. comorbid conditions, n (%) | Â | Â | Â | Â | Â |
Hypertension | 13 (26.0%) | 26 (52.0%) | 9 (18.0%) | 18 (36.0%) | 0.002 |
Hypercholesterolemia | 0 (0.0%) | 4 (8.0%) | 4 (8.0%) | 8 (16.0%) | 0.034 |
Diabetes | 8 (16.0%) | 3 (6.0%) | 6 (12.0%) | 3 (6.0%) | 0.261 |
No. smoking status, n (%) | Â | Â | Â | Â | < 0.001 |
Never | 35 (70.0%) | 22 (44.0%) | 12 (24.0%) | 6 (12.0%) | |
Former | 12 (24.0%) | 22 (44.0%) | 22 (44.0%) | 14 (28.0%) | |
Current | 3 (6.0%) | 6 (12.0%) | 16 (32.0%) | 30 (60.0%) | |
No. alcohol status, n (%) | Â | Â | Â | Â | Â |
Never | 28 (56.0%) | 20 (40.0%) | 15 (30.0%) | 6 (12.0%) | < 0.001 |
Former | 7 (14.0%) | 6 (12.0%) | 9 (18.0%) | 18 (36.0%) | |
Current | 15 (30.0%) | 24 (48.0%) | 26 (52.0%) | 26 (52.0%) | |
No. ISUP grade, n (%) | Â | Â | Â | Â | Â |
Low-grade (1–2) | 10 (20.0%) | 20 (40.0%) | 46 (92.0%) | 40 (80.0%) | < 0.001 |
High-grade (3–4) | 40 (80.0%) | 30 (60.0%) | 4 (8.0%) | 10 (20.0%) |